Press Releases with tag "vaccines"
Latin America Animal Health Care Market Outlook to 2016 - Demand for Dairy and Meat Products Driving the Veterinary Health Marketi-Newswire, 2012-08-18
The report provides a comprehensive analysis of market size of global and Latin America animal health care industry, market segmentation of Latin America animal health care industry by pharmaceuticals, vaccines and medical feeds.
Global Markets For Vaccines – United States, United Kingdom, India, Germany, China, Japan, South Korea, Chile, Argentina, France, Austria, Czech Republic, Etc.
i-Newswire, 2012-03-14
Global Research & Data Services is going to publish several market analyses about the markets for vaccines around the world.
Pro Pharma Announces Newly Enhanced & Expanded JCode Calculator™ V2
i-Newswire, 2011-11-01
Pro Pharma Pharmaceutical Consultants, Inc., a pharmaceutical consultant organization which focuses on data analytical expertise, announced today that it has introduced new-improved enhancements to the JCode Calculator™ for claims and billing exper
GeoVax Labs’ CSO and Chairman Receive Academic Honors
i-Newswire, 2011-09-29
CSO Harriet L. Robinson Honored as Distinguished Emeritus Faculty; Chairman David A. Dodd To Receive Alumni Award from Georgia State University
FastMed Provides $15 Flu Vaccinations in North Carolina
i-Newswire, 2011-09-16
FastMed Urgent Care provides individual adult and children’s flu vaccinations for $15 at all of their North Carolina locations
Dr. John Heinrichs, Director At Merck & Co., To Speak At Vaccines Meeting On Nov. 7-8 In Boston, MA.
i-Newswire, 2011-08-15
Dr. Jon Heinrichs, Director, Microbial Vaccines, Merck Research Laboratories, to deliver featured speech at 9th Annual Vaccines Discovery and Development: All Things Considered Conference (Nov. 7-8, 2011, in Boston, MA).
Erik Henchal, Associate Director At FDA To Speak At Vaccines Meeting On Nov. 7-8 In Boston, MA
i-Newswire, 2011-07-31
Erik Henchal, Associate Director, Management and Scientific Affairs, Office of Vaccine Research and Review Food and Drug Administration, to deliver featured speech at 9th Annual Vaccines Discovery and Development: All Things Considered Conference.
GeoVax Trial Results Establish a New Benchmark for Preventative HIV Vaccine Model
i-Newswire, 2011-06-08
Non Human Primate Study Demonstrates Unprecedented 70% Prevention of Infection
New Book Discloses Why Vaccines Do Not Prevent Disease
i-Newswire, 2011-05-23
New scientific findings and statistical data disclose that vaccines not only fail to prevent the diseases they are supposed to protect us from, but they actually cause or contribute to them.
Markets For Vaccines In Europe – Germany, Russia, Italy, UK, Ireland, Sweden, Finland, Portugal, Austria, Norway, France, Poland Etc.
i-Newswire, 2011-04-18
Today, Global Research & Data Services is going to publish several market analyses about the markets for vaccines in different European countries.
Encouraged by Early Clinical Studies, A Biotech Company Expands Its HIV/AIDS Vaccine Program
i-Newswire, 2011-04-14
GeoVax has decided to expand its preventative HIV/AIDS vaccine development effort in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) and the HIV Vaccine Trials
GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
i-Newswire, 2011-02-23
The article, titled “Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles,” will appear in the March 1 issue of The Journal of Infectious Diseases.
New Biomedical Treatment for Autism Website Shares Video Interviews
i-Newswire, 2010-12-25
Biomedical Treatment for Autism is a new website that shares video interviews of parents, researchers and medical professionals talking about alternative medical interventions that reverse the symptoms of Autism.
GeoVax Awarded Federal Grant Under The Qualifying Therapeutic Discovery Project Program
i-Newswire, 2010-11-04
The grant was awarded following GeoVax’s submission for consideration of its HIV/AIDS vaccine research and development project to the U.S. Secretary of Health and Human Services.
One Company Aims to Repurpose a Smallpox Vaccine to Battle HIV
i-Newswire, 2010-08-23
Because of the difficulty raising antibodies that are capable of totally blocking natural HIV infections, the GeoVax vaccine approach has focused on raising cellular immune responses in addition to antibodies.
Newly Discovered Antibodies May Boost AIDS Vaccine Research
i-Newswire, 2010-07-13
GeoVax is developing a vaccine that presents the natural form of HIV envelope proteins to the immune system on virus-like particles with the envelope proteins present in clusters of three, a confirmation known as trimers.
Early Diagnosis and Treatment for HIV Has Life-Saving Impact on Patients
i-Newswire, 2010-06-22
Since 1995, National HIV Testing Day has united organizations across the nation every June 27th to promote the early diagnosis of HIV.
New Progress for HIV/AIDS Therapeutic Vaccine As First Trial Moves Forward
i-Newswire, 2010-06-11
Although the GeoVax vaccines are currently being studied for HIV prevention, this is the first study using the same products for treatment of persons who already have HIV infection. ARCA is the only site for this trial.
NewsRx Publishes Encyclopedia of Vaccines, 2009: An encyK Resource for Parents, Patients & Professionals
i-Newswire, 2010-01-28
NewsRx has published a new encyclopedia on vaccines -- Encyclopedia of Vaccines, 2009: An encyK Resource for Parents, Patients & Professionals.
Tuberculosis (TB) vaccines reducing TB patients
i-Newswire, 2009-12-15
Tuberculosis is known to exist even before the year 2000BC, and writings from Egypt and Babylon mention it. Even the in the Greek literature there can be found information about physician and local doctors considered this disease to be very dangerous
